Pursuits
Acura, Inthinc, Boston Beer, Opera: Intellectual Property
This article is for subscribers only.
Acura Pharmaceuticals Inc., whose technology helps deter drug abuse, sued Ranbaxy Laboratories Ltd., India’s largest drugmaker, over its plan to market a generic version of the painkiller Oxecta.
Acura, based in Palatine, Illinois, claimed New Delhi-based Ranbaxy wrongly plans to market a copy of the short-acting oxycodone pill before Acura’s patent expires in 2025, according to papers filed April 29 in federal court in Delaware.